BGSF
BGSF, Inc.
There isn't enough reported data to score BGSF yet.
CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
BGSF Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Unavailable | |
| Weak |
BGSF's revenue, profitability and balance sheet are currently under pressure. There isn't enough data to rate its cash flow.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
BGSF PE Valuation
BGSF has no meaningful PE right now: it lost money over the past year.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
BGSF Forward outlook
There aren't enough analyst estimates for BGSF to show an outlook.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
BGSF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.19 | +$0.84 |
BGSF is still losing money, but far less than before: $0.19 per share over the past year, against $1.03 at its worst in late 2025.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over BGSF in the latest year-over-year earnings comparison.
BGSF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25.1M | -6.6% |
| Q2 2026 | $22.3M | -5.1% |
| Q1 2026 | $20.9M | -67% |
| Q4 2025 | $22M | -66% |
| Q3 2025 | $26.9M | +37681% |
| Q2 2025 | $23.5M | +34398% |
| Q4 2024 | $64.4M | -12% |
| Q4 2023 | $73.6M | -4.8% |
BGSF's revenue has slid since its 2021 peak: $25M last quarter, down 6.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.8% | N/A |
| Q2 2026 | -5.3% | +14 points |
| Q1 2026 | -7.4% | N/A |
| Q4 2025 | -8% | -9.9 points |
| Q2 2025 | -19% | -19 points |
| Q4 2024 | 1.9% | +12 points |
| Q3 2024 | 0.7% | N/A |
| Q2 2024 | 0.1% | N/A |
BGSF's operating margin was 0.8% last quarter, up 20 points from the same quarter a year ago.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over BGSF on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over BGSF on profitability, with a higher operating margin.
BGSF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $1.7M | -93% |
| Q4 2024 | $22.7M | +28% |
| Q4 2023 | $17.8M | +$18.1M |
| Q4 2022 | -$291.8K | -111% |
| Q3 2022 | -$7.9M | -5272% |
| Q2 2022 | -$2.2M | -$1.4M |
| Q1 2022 | -$2.4M | -279% |
| Q4 2021 | $2.7M | -29% |
BGSF has the stronger cash trend. Its trailing FCF is up 140% versus its history, compared with CAT at up 39%.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
BGSF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -21K shares |
| 1 year | -4.6% | -514K shares |
BGSF has the edge over CAT on shareholder dilution, with a more favorable share count trend.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
BGSF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | 4.0x | High |
| Q3 2024 | 0.0x | Very low |
| Q4 2022 | 2.0x | Healthy |
| Q3 2022 | 0.0x | Very low |
| Q2 2022 | -0.0x | Very low |
| Q1 2022 | 0.0x | Very low |
| Q4 2021 | 1.5x | Healthy |
| Q3 2021 | 1.5x | Healthy |
BGSF's net debt is about 4.0 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
BGSF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.3 | Neutral |
| Stochastic | 15.1 | Oversold |
BGSF's weekly RSI is 31 (neutral) and its Stochastic is 15 (oversold).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BGSF PE vs Industrials Sector
| Metric | BGSF | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
BGSF has no meaningful PE right now: it lost money over the past year.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
BGSF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.37 | 13% below |
| 20 week MA | $5.04 | 24% below |
| 50 week MA | $5.35 | 29% below |
| 100 week MA | $5.13 | 26% below |
| 200 week MA | $7.28 | 48% below |
BGSF is in a downtrend: it's below all five of its weekly moving averages, and 48% below its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over BGSF on trend strength, trading above more of its moving averages.
BGSF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.2 | $12.6 | -40% |
| 2021 | $12.6 | $14.0 | +11% |
| 2022 | $14.0 | $15.0 | +7.1% |
| 2023 | $15.0 | $9.40 | -37% |
| 2024 | $9.40 | $6.14 | -35% |
| 2025 | $6.14 | $4.76 | -22% |
| 2026 YTD | $4.76 | $3.82 | -20% |
BGSF has finished three years in a row lower, and it's down 20% so far in 2026.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over BGSF on returns for 2026, with the stronger performance.